0.3150
+0.0050
+(1.61%)
At close: January 10 at 3:42:48 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-37,176.0000
-44,590.0000
-32,322.0000
-43,304.0000
-33,891.0000
Investing Cash Flow
1,956.0000
9,960.0000
30,066.0000
-35,208.0000
12,628.0000
Financing Cash Flow
27,463.0000
6,910.0000
116.0000
226.0000
58,807.0000
End Cash Position
7,963.0000
9,252.0000
36,970.0000
39,114.0000
117,393.0000
Capital Expenditure
--
-29.0000
-24.0000
-212.0000
-79.0000
Issuance of Capital Stock
17,654.0000
6,881.0000
101.0000
36.0000
58,402.0000
Free Cash Flow
-37,176.0000
-44,619.0000
-32,346.0000
-43,516.0000
-33,970.0000
12/31/2020 - 4/25/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
CSCI.TO COSCIENS Biopharma Inc.
5.0000
+2.25%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
KNBIF Kane Biotech Inc.
0.0773
0.00%
KNE.V Kane Biotech Inc.
0.1100
0.00%
WXIBF WuXi Biologics (Cayman) Inc.
2.1900
+0.92%
TH.TO Theratechnologies Inc.
2.6900
-7.88%
HBP.TO Helix BioPharma Corp.
0.8900
-4.30%